Copper Single-Atom MOF for Ultrasound-Enhanced Therapy

The study Copper Single-Atom-Based Metal−Organic Framework for Ultrasound-Enhanced Nanocatalytic Therapy addresses a central problem in chemodynamic therapy (CDT): tumor-associated chemistry is often insufficient to sustain high reactive oxygen species production. The authors construct FA-NH2-UiO-66-Cu, abbreviated FNUC, as a multifunctional nanozyme that combines isolated copper sites, a porous metal–organic framework, folic acid modification, and an IR-1061-based NIR-II imaging readout.

The work is important because it treats catalysis, redox resistance, targeting, and imaging as connected design requirements rather than independent features. Its central contribution is not simply the incorporation of copper into a MOF, but the use of structurally defined copper sites to improve atom utilization while using ultrasound to intensify hydroxyl radical generation.

Study Background and Research Question

CDT relies on endogenous substrates in the tumor microenvironment (TME), particularly hydrogen peroxide, to generate highly reactive species such as hydroxyl radicals. In principle, a Cu+-mediated Fenton-like reaction can be effective under the mildly acidic conditions of tumors. In practice, the concentration of hydrogen peroxide may be limiting, while glutathione (GSH) and other reducing substances can neutralize oxidative stress before it damages tumor cells.

Conventional metal clusters can provide catalytic activity, but their surface atoms are not equally accessible or chemically equivalent. They may also require relatively high metal loading and can present concerns about uncontrolled active sites and toxicity. The research question was therefore whether isolated copper atoms anchored in NH2-UiO-66 could provide more efficient redox catalysis, consume intracellular GSH, and respond to an external ultrasound trigger.

The choice of copper is chemically motivated. Cu2+ is more stable than Cu+ in a nanomaterial, and its reduction by GSH can both weaken the antioxidant environment and generate Cu+ species. The resulting Cu2+/Cu+ cycle is intended to connect GSH depletion with continued conversion of hydrogen peroxide into hydroxyl radicals.

Key Innovation from the Reference Study

FNUC integrates four functional elements. NH2-UiO-66 supplies a porous coordination environment; atomically dispersed Cu2+ sites provide the catalytic center; folic acid is used as a targeting ligand; and IR-1061 enables NIR-II fluorescence imaging. The paper characterizes the material as a Cu2+-based single-atom nanoenzyme, while the reduced Cu+ state generated during GSH consumption supports peroxidase-like activity.

This architecture differs from a conventional copper nanoparticle or cluster in two important ways. First, isolated sites maximize the fraction of copper atoms that can participate in catalysis. Second, the coordination environment is sufficiently defined to permit structural analysis and computational modeling. These features make it possible to connect material structure with reaction behavior more directly than is usually possible for poorly defined metal aggregates.

Ultrasound supplies the external control element. According to the reference study, ultrasound-induced cavitation promotes hydroxyl radical production by FNUC. This does not replace the endogenous chemistry of the TME; rather, it is presented as a way to accelerate or amplify a reaction that is otherwise constrained by substrate availability and antioxidant buffering.

Methods and Experimental Design Insights

The materials workflow begins with NH2-UiO-66, followed by copper coordination to produce the single-atom catalyst, referred to as NUC before folic acid and imaging-related modification. The authors use folic acid functionalization to generate FNUC and assess the resulting morphology, composition, crystallinity, optical properties, and chemical bonding. Electron microscopy includes SEM, TEM, STEM, elemental mapping, and EDS. XRD evaluates whether the MOF framework is retained, while UV–visible and FT-IR spectroscopy monitor optical and functional-group changes.

Single-atom assignment is supported by several complementary techniques rather than by one image alone. Spherical-aberration-corrected TEM is used to inspect isolated copper sites. Cu K-edge XANES and EXAFS probe oxidation state and local coordination, and EXAFS fitting provides a structural model for the copper environment. Wavelet-transform EXAFS comparisons with copper reference compounds further distinguish isolated-site behavior from metallic or oxide-like copper. XPS analysis of nitrogen environments helps assess how copper coordination affects the amino-functionalized framework.

The computational component is also relevant. Density functional theory models several possible ways for copper atoms to interact with the NH2-UiO-66 framework, including interactions involving amino groups and zirconium oxide clusters. These calculations do not by themselves prove that every site in the experimental material has one identical geometry, but they provide chemically plausible structures for interpreting the spectroscopy and catalytic data.

Functionally, the study compares GSH consumption, peroxidase-like activity, hydroxyl radical formation, and ultrasound-assisted catalysis. Kinetic analysis examines the Michaelis constant and hydroxyl radical generation rate, while cellular and animal experiments evaluate antitumor activity. IR-1061-based NIR-II fluorescence imaging is used to investigate tumor-associated localization and connect material distribution with treatment performance.

Protocol Parameters

• Framework preparation: Use NH2-UiO-66 as the defined porous host, then coordinate copper under conditions that preserve framework crystallinity and minimize formation of copper clusters.
• Site verification: Treat aberration-corrected microscopy, XANES, EXAFS, XPS, and elemental analysis as complementary characterization requirements; a single microscopy image is not sufficient to establish single-atom dispersion.
• Redox assay design: Measure GSH depletion and hydroxyl radical production together, because the proposed mechanism depends on coupling antioxidant consumption with Cu+-associated peroxidase-like chemistry.
• Ultrasound comparison: Include matched FNUC conditions with and without ultrasound and report acoustic settings, exposure duration, medium, and temperature control. These experimental parameters should be taken from the full paper and supporting information rather than inferred from the condensed findings.
• Imaging interpretation: Use the NIR-II signal to assess distribution and targeting, but independently evaluate catalytic activity and therapeutic response; fluorescence intensity alone does not establish ROS production.

Core Findings and Why They Matter

The first meaningful finding is that the material exhibits the structural signatures expected for atomically dispersed copper in an NH2-UiO-66 environment. This matters because the claimed catalytic advantage depends on isolated active centers, not merely on the presence of copper. The spectroscopy and microscopy package therefore supports the study’s structure–function argument.

The second finding is mechanistic. FNUC consumes GSH through copper redox chemistry, reducing an important intracellular antioxidant defense. The resulting Cu+ species can then participate in peroxidase-like conversion of residual hydrogen peroxide into hydroxyl radicals. This sequential model addresses two limitations of CDT at once: weak oxidant supply and excessive reductive buffering.

Ultrasound further improves the reaction. The authors report a faster hydroxyl radical generation rate, a lower Michaelis constant, and a larger hydroxyl radical concentration under ultrasound activation. These kinetic observations are interpreted as evidence that cavitation improves contact or reaction conditions for the catalytic process. The important point is that ultrasound is used as a catalytic amplifier rather than as an unrelated physical treatment.

Biological experiments show antitumor activity in vitro and in vivo, while NIR-II fluorescence imaging supports the proposed tumor-targeting behavior of FNUC. In this design, IR-1061 is not the therapeutic mechanism; it is the optical component that helps visualize where the nanocatalyst accumulates. This distinction is important for researchers evaluating the platform as a fluorescent dye for biomedical research, a fluorescent dye for in vivo imaging, or a fluorescent dye for molecular imaging.

Collectively, the findings support a systems-level design principle: a useful CDT nanoplatform may need an efficient active site, a mechanism for weakening antioxidant defenses, an external trigger for reaction control, and an imaging function for localization. The paper links these functions within one material while retaining a chemically interpretable catalytic center.

Comparison with Existing Internal Articles

The internal article IR-1061: Benchmark Near Infrared Fluorescent Dye for Deep Imaging provides broader context for why an NIR-II dye is useful in a nanocatalytic platform. Its emphasis is optical contrast and reduced background autofluorescence, whereas the reference study is primarily concerned with catalytic redox chemistry, ultrasound enhancement, and tumor response. The two resources are complementary, but the dye overview should not be treated as evidence for FNUC efficacy.

A second useful comparison is Enantiomeric Polymer Structure Tunes IR-1061 Encapsulation for NIR-II Imaging. That article focuses on polymer–dye interactions and encapsulation efficiency. It is relevant when designing or troubleshooting an optical formulation, but FNUC uses IR-1061 as part of a MOF-based imaging construct. Consequently, solvent environment, loading strategy, fluorescence quantum yield, and colloidal behavior may differ substantially between the systems.

Limitations and Transferability

The study provides a persuasive proof of concept, but several limitations affect transferability. First, single-atom characterization describes an ensemble of sites and a distribution of local environments. DFT models clarify plausible coordination structures, yet they cannot guarantee that all copper atoms in a batch occupy the same geometry or oxidation state during biological use.

Second, ultrasound-enhanced catalysis is highly dependent on acoustic conditions, sample concentration, tissue depth, dissolved gases, and heat management. The reported improvement should therefore not be generalized to every ultrasound instrument or tumor model without reoptimization. A reproducible translation workflow would need detailed reporting of acoustic pressure, frequency, pulse structure, exposure time, and temperature.

Third, GSH and hydrogen peroxide levels vary among cell types, tumor regions, and animal models. A platform that performs well in a strongly reducing, peroxide-containing TME may show less activity in tumors with different redox balance. Likewise, folate-associated uptake does not prove exclusive tumor selectivity, and NIR-II fluorescence indicates localization rather than catalytic flux or intact-particle persistence.

Why this cross-domain matters, maturity, and limitations

Combining nanocatalytic therapy with optical imaging is valuable because treatment response can be interpreted alongside material distribution. However, the imaging and therapy functions remain analytically distinct: a bright signal does not necessarily mean high hydroxyl radical output, and strong catalytic activity does not guarantee favorable biodistribution. The reference study therefore represents an early translational platform rather than a clinically validated theranostic system. Long-term copper exposure, MOF degradation, clearance, immune effects, repeat-dose behavior, and the stability of the IR-1061 formulation require additional study before clinical conclusions are justified.

Research Support Resources

For related optical workflows, researchers can use IR-1061 (SKU C8242) as a near infrared fluorescent dye for optical imaging, provided that its formulation is validated for the intended nanomaterial. APExBIO product information describes it as a NIR dye for OTN-NIR applications, soluble in DMSO but insoluble in ethanol and water, and recommends tightly sealed, desiccated storage at −20 °C. Freshly prepared solutions and appropriate formulation controls are advisable because dye handling can influence fluorescence and nanoparticle performance.